Table: begin end state 1 26 cytoplasmic 27 48 transmembrane 49 56 non-cytoplasmic 57 77 transmembrane 78 91 cytoplasmic 92 111 transmembrane 112 116 non-cytoplasmic 117 139 transmembrane 140 150 cytoplasmic 151 174 transmembrane 175 185 non-cytoplasmic 186 206 transmembrane 207 253 cytoplasmic 254 276 transmembrane 277 290 non-cytoplasmic 291 311 transmembrane 312 319 cytoplasmic 320 336 transmembrane 337 341 non-cytoplasmic 342 363 transmembrane 364 373 cytoplasmic 374 397 transmembrane 398 408 non-cytoplasmic 409 428 transmembrane 429 449 cytoplasmic
Input: >AO356_01235 VNTSSLKANAGADPVLLSAIAKVKRHILPLFVIMFIVNYIDRVNIGFVRAHMEHDLGIGA AAYGFGAGLFFIGYALFEVPSNILLQRIGARIWLTRIMLTWGLVAAAMAFIQNETHFYIL RFLLGVAEAGFFPGVIYYFTRWLPGVERGKAIAIFLSGSAIASLISGPLSGLLLQINGLG MHGWQWMYFIEGMFSVCLCVFVWFWLDSKPHDAKWLSREEQDVLVKAIDDEQRAREAASP IKLSIGQLLKDRQIILFCLIYFFIQLTIYAATFWLPSIIKKMGELSDIQVGLFNSIPWLL SIVGMYAFASLSAKWKFQQAWVATALLIAAAGMFMSTTGGPIFAFVAICFAALGFKSASS LFWPIPQAYLDARIAAGVIALINSVGNLGGFVAPTTFGLLEEHTGSIQGGLYGLAATSII AAIIVFAARNTPKPKAVTTTPVDPAASHV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server